Company intelligence / Profile preview

Mirexus

Guelph, Ontario, Canada
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Mirexus is a Canadian biotechnology company that has developed a unique, plant-based nanotechnology platform based on PhytoSpherix, a monodisperse phytoglycogen nanoparticle. Extracted from non-GMO sweet corn, these highly branched glucose polymers are non-toxic, biodegradable, and possess exceptional water-retention and film-forming properties. The company targets three primary markets: personal care, where PhytoSpherix is used as a high-performance moisturizing and anti-aging ingredient; nutraceuticals; and biomedical applications, including drug delivery and vaccine adjuvants. In September 2022, Mirexus was acquired by BASF, the world's largest chemical producer, to bolster its portfolio of sustainable and bio-based ingredients for the Care Chemicals division. The acquisition allows for the global scaling of the PhytoSpherix technology across various industrial and healthcare sectors.

Therapeutic areas
OtherDermatology
Modalities
Nanoparticle
Industry
Non-Drug Biotech
02

Partnerships

BASF

Beyond the preview

Go deeper on Mirexus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mirexus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call